We are live on
!
Find out more
TRIB
Trinity Biotech
TRIB
TRIB
64 hedge funds and large institutions have $191M invested in Trinity Biotech in 2013 Q2 according to their latest regulatory filings, with 64 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
50% less call options, than puts
Call options by funds: $169K | Put options by funds: $337K
Holders
64
Holders Change
+64
Holders Change %
–
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
64
Increased
–
Reduced
–
Closed
–
Calls
$169K
Puts
$337K
Net Calls
-$168K
Net Calls Change
-$168K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
TRIB Hedge Fund Activity: Q2 2013 in Review
64 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q2 2013, worth a combined $191M.
Buyers outnumbered sellers: 64 funds opened new TRIB positions and 0 closed out — a net gain of 64 holders — while 0 added to existing stakes and 0 trimmed.
- 64 institutional investors held Trinity Biotech (TRIB) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $191M of Trinity Biotech stock for Q2 2013.
- 64 funds opened new Trinity Biotech positions in Q2 2013 and 0 closed out, a net change of +64 holders.
Based on aggregated 13F filings for Q2 2013.